Skip to content
HOME
NEWS
MISSION
APTAMER
MACE® Tech
TEAM
CONTACT US
English
日本語
English
HOME
NEWS
MISSION
APTAMER
MACE® Tech
TEAM
CONTACT US
English
日本語
English
Separation science promotes
drug discovery research
LEARN MORE
News and Announcements
We are pleased to announce that Nikkei Biotechnology has published the latest article on MACE® Tech for Aptamer Screening which includes commentary from our CTO Professor Keitaro Yoshimoto. (May 13, 2022) •
Funakoshi has published a new article about LinkBIO MACE® Technology for Aptamers Separation and how it could accelerate both Therapeutics and Diagnostics Discovery P5~7). (March 1, 2022)
We are happy to announce that we successfully got our MACE® Trademark Registration (Trademark Registration No. 6515690)- (February 18, 2022)
We are pleased to announce the Grant of Japan Patent No. 6994198 for “Methods for screening nucleic acid aptamers”. (December 15, 2021)
Strategic Alliance Agreement with Funakoshi (December 1, 2021)• Announcement of collaborative research contract with Maruho Co., Ltd. (October 13, 2021)• Academic paper related MACE® was accepted (Sep. 22, 2021)
Patent registration in China (Sep. 21, 2021)• Appointment of new advisor (Sep. 01, 2021)
Receipt of subsidies (July. 15, 2021)
Patent registration in Taiwan (Jun 21, 2021)• Patent registration in USA (Apr. 13, 2021)
Appointment of new director (Mar. 06, 2021)• Receipt of subsidies (Jan. 22, 2021)
NEWS
MISSION
APTAMER
MACE
TEAM
CONTACT